Where to buy Epithalon has five plausible answers, and the mistake almost everyone makes is treating them as five prices for one item. They are five different businesses, selling four different things, under one name that two of them spell differently.
Key takeaways
- Only one channel reliably hands over a lot-numbered vial with a certificate attached to that specific lot, and that is a domestic research-peptide supplier.
- The compounding pharmacy row is empty. Epitalon was nominated, placed in category 2 under FDA's interim policies, then withdrawn, so it appears on no current category list and there is no prescription path.
- Longevity and anti-ageing clinics do market this compound, unlike most peptides on this site, and what they are selling is consultation and administration rather than a cheaper vial.
- Oral capsule storefronts are selling a different format with no stated milligram content, so their price cannot be compared against a 10 mg vial at all.
- FDA's concern is immunogenicity from aggregation and peptide-related impurities. That is a handling question, and handling is precisely what changes between these five rows.
Every row below gets measured against one real listing, so here is the reference point up front rather than at the end.
The vendor we point lifters to
Epithalon from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 23, 2026.
Where to buy Epithalon: the five channels side by side
| Channel | What arrives | Where the risk sits | Typical cost |
|---|---|---|---|
| Domestic research supplier | Lyophilised vial, lot number, batch certificate, research-use labelling | Testing scope varies lot to lot, and no clinical oversight exists at any point | Roughly $2 to $6 per mg before codes |
| Longevity or anti-ageing clinic | Administration and a consultation, product sourcing usually undisclosed | You are paying for a service and inheriting whatever the clinic bought | Highest by a wide margin, priced per visit |
| Oral capsule storefront | Capsules sold under a pineal peptide heading, total content rarely stated | No milligram figure means no comparison and no idea what you took | Priced per bottle, never per mg |
| Compounding pharmacy | In practice nothing, because the nomination was withdrawn | A pharmacy that offers it anyway is the warning, not the workaround | Not meaningfully priced |
| Overseas bulk or group buy | Minimally labelled powder, generic or absent certificate | Customs, cold chain, no lot traceability, nobody to contact afterwards | Lowest per mg, by a lot |
Two of those rows quietly destroy any price comparison a reader tries to run. The capsule row has no unit, and the clinic row is not selling a vial at all.
The clinic row, and what one is actually selling you
This compound differs from most of what this site covers, because anti-ageing and longevity clinics genuinely do market it. Search for a local option and you will find real businesses with real phone numbers, which is not the case for many research peptides.
What is being sold there needs stating plainly. A clinic sells time with a practitioner, an administration setting, and a supply chain it chose on your behalf. Those first two have real value if you want oversight. The third is where the transaction gets opaque, because a clinic is under no obligation to tell you which manufacturer produced the material, which lot it came from, or what its certificate covered, and many will not volunteer it.
Which means the clinic row does not remove the sourcing problem from this article. It moves it behind a counter. The question that puts it back on the table is the same one you would ask a supplier: which lot is this, and what does its certificate cover. A clinic that can answer is worth its markup. A clinic that treats the question as impertinent has told you what its own diligence looks like.
There is no FDA-approved Epithalon product, so nothing a clinic administers is an approved medicine, whatever the setting implies.
Why the pharmacy row is empty
Most readers arrive assuming this row exists, so here is the position stated precisely.
Epitalon was nominated as a bulk drug substance for use in compounding. It was placed in category 2 under FDA's interim policies while the agency evaluated it, and the nomination was later withdrawn by the nominator. It now sits on FDA's safety risks page, content current as of 04/22/2026, under "Bulk drug substances nominated but withdrawn", a table the agency describes as listing substances previously in category 2 that the nominators pulled. It is absent from the 503A bulk substances page, content current as of 05/14/2026, in every category.
So "Epitalon was category 2" is out of date, "Epitalon is category 2" is wrong, and "Epitalon is on no current category list" is the accurate version. This is the same sequence that closed the pharmacy route on the other two Russian peptides this site covers, laid out with the same documents in where to buy Semax.
The practical consequence is not that the pharmacy route is harder. It is that it is not a route, and a business offering one is either confused or counting on you being.
The research supplier row, and what the document has to contain
This is the channel that works, because the thing being sold is a defined object with paperwork attached.
Epithalon is a synthetic tetrapeptide, four residues, Ala-Glu-Asp-Gly, developed by Vladimir Khavinson's group in Russia as a synthetic version of a pineal extract called epithalamin. PubChem CID 219042 records the formula as C14H22N4O9 and the molecular weight as 390.35, under the spelling Epitalon that FDA also uses. That public reference is what makes a certificate checkable instead of decorative.
The certificate published for this compound covers batch 15-05260628, analysed by Kovera Labs, report KVR-2026-A36FF4, certified 05/23/2026. It reports purity at 99.312% against a greater-than-98% specification, confirmed identity, an endotoxin screen against a 0.5 EU/mL acceptance limit reported as a pass, a microbial sterility screen returning no growth, heavy metals including arsenic, cadmium and mercury screened, and net content of 9.64 mg against a 10 mg label with a specification of 10 mg plus or minus 10 percent.
Read that last figure twice, because it is the most useful number in this article. The fill is inside tolerance and under the printed weight. At the discounted $25.00 that means $2.50 per milligram if you trust the label and $2.59 per milligram against what was actually measured. This site prints both. It is also, quietly, a mark in the vendor's favour: publishing a fill weight that undercuts your own label copy is not what a company does when its documents are decorative.
Why the cheap rows lose on risk even when the powder is real
FDA's written concern about this substance is specific rather than sweeping. Compounded drugs containing epitalon, the agency says, may pose a risk of immunogenicity for certain routes of administration because of the potential for aggregation and peptide-related impurities, and it states that it has not identified safety-related information for the proposed route of administration.
That is a manufacturing statement. Aggregation and peptide-related impurities are consequences of synthesis, purification, drying, filling, transport and storage, not of the molecule having some intrinsic property that a purity number would reveal. Bacterial endotoxin belongs to the same family of problems, it persists after the organisms that made it are gone, and the acceptance limits it is judged against are the ones the bacterial endotoxins test in USP Chapter 85 is built around.
So a parcel that spent three weeks crossing borders in ambient heat can contain genuine Epithalon and still be a worse purchase than a domestically warehoused vial at twice the price. The peptide is real and the handling is unknown, and the handling is the part FDA is actually worried about. The same reasoning, applied where the documented failure was a different one, is in how to get NAD+.
Where can I buy Epithalon, once the rows that do not deliver are removed
Set aside the capsule row as a different product with no comparable unit, the pharmacy row as an empty one, and the overseas rows as a trade of price for traceability, and the honest answer to where to buy Epithalon peptide is a domestic research supplier that publishes a lot-specific certificate. The clinic row remains legitimate if what you want is supervision, at a price and with a sourcing question you will have to ask out loud.
None of which is an argument that a lifter should buy any of it. Epithalon is sold against ageing, telomeres and telomerase, and that case rests largely on work from one Russian research group that has not been replicated to Western standards. A PubMed search for epitalon shows a literature dominated by that lineage, and ClinicalTrials.gov lists no registered study with it as an intervention. If what you actually want is to keep training capacity into your fifties and sixties, the biology with human evidence behind it is duller and better mapped, and we cover the central mechanism in myostatin and sarcopenia.
Frequently asked questions
Where can I buy Epithalon in the United States?
Realistically from a domestic research-peptide supplier that publishes a certificate tied to the lot number on the vial. There is no compounding pharmacy route because the bulk nomination was withdrawn, and there is no FDA-approved Epithalon product for a prescriber to write against.
Is it spelled Epithalon or Epitalon?
Both, for the same molecule. FDA and PubChem use Epitalon, and the peptide market mostly uses Epithalon. If you are searching for where to buy Epitalon and getting different results, that is a spelling artefact rather than two products. PubChem CID 219042 covers it under either name.
Are the oral capsules the same as the injectable vial?
They are a different format sold on the same story. Capsule listings rarely state total peptide content, so there is no milligram figure to compare against a vial price, and an oral route raises entirely separate questions about what survives digestion. Treat the two as different purchases, not two prices.
Why is overseas Epithalon so much cheaper per milligram?
Because most of the domestic price is not the peptide. It is lot-specific third-party testing, domestic warehousing, dispatch someone is accountable for, and a business you can contact. Overseas bulk removes all four, along with any recourse if the parcel is seized or simply never arrives.
Is any of this going to help my lifting?
No seller claims it will, and neither do we. Epithalon is marketed on telomere and longevity claims from a narrow and largely Russian-language research base, with no registered trials. You would be buying an anti-ageing claim, which is a legitimate thing to decide to buy, but it is not a training decision.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Epitalon, PubChem CID 219042
- Certificate of analysis, Epithalon batch 15-05260628, Kovera Labs
- Published research on epitalon, PubMed
- Registered studies of Epitalon, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Epithalon holds no FDA approval for any indication, has no US prescription route, and material sold by research suppliers is labelled for laboratory use only and not for human consumption. Claims about telomeres, telomerase and lifespan associated with this compound come largely from a single research lineage and have not been replicated to Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or unapproved compounds.